CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)		Total	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Class A Ordinary Shares Subject To Redemotion	Class A Ordinary Shares Subject To Redemotion Common Stock	Class A Ordinary Shares Subject To Redemotion Additional Paid-in Capital	Class A Ordinary Shares	Class A Ordinary Shares Common Stock		Class B Ordinary Shares		Class B Ordinary Shares Common Stock
Beginning Balance (in shares) at Jan. 23, 2020									0				0
Beginning Balance at Jan. 23, 2020		$ 0	$ 0	$ 0					$ 0				$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(112,317)		(112,317)
Ending Balance (in shares) at Mar. 31, 2020									0				0
Ending Balance at Mar. 31, 2020		(112,317)	0	(112,317)					$ 0				$ 0
Beginning Balance (in shares) at Dec. 31, 2020						0		0	0	[1]	25,000,000	[2]	25,000,000	[1]
Beginning Balance at Dec. 31, 2020	[1]	11,155	22,500	(13,845)					$ 0				$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance (in shares)									100,000,000
Sale of Units in initial public offering, net of underwriter commissions, offering expenses and fair value of warrants		915,532,727	915,522,727						$ 10,000
Shares subject to possible redemption (in shares)									(93,092,438)
Shares subject to possible redemption					$ (930,924,380)	$ (9,309)	$ (930,915,071)
Net income (loss)		20,380,504		20,380,504
Ending Balance (in shares) at Mar. 31, 2021								6,907,562	6,907,562		25,000,000		25,000,000
Ending Balance at Mar. 31, 2021		$ 5,000,006	$ (15,369,844)	$ 20,366,659					$ 691				$ 2,500

[1] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.

[2] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.